Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

A Balloch; PV Licciardi; FM Russell; EK Mulholland; MLK Tang

Journal article

Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

A Balloch, PV Licciardi, FM Russell, EK Mulholland, MLK Tang

Journal of Allergy and Clinical Immunology | Published : 2010

DOI: 10.1016/j.jaci.2010.05.008

Abstract

This is the first study examining serotype-specific IgG responses following immunization with the polysaccharide vaccine Pneumovax® in infants aged 12 months in the absence of prior pneumococcal conjugate vaccine priming.

University of Melbourne Researchers

Paul Licciardi Author

Fiona Russell Author

Mimi Tang Author

Related Projects (2)

A study to investigate alternative regimens for pneumococcal vaccination of infants in a developing country

Streptococcus pneumoniae (Pnc) is the leading vaccine preventable cause of serious infection in infants. The current Pnc conjugate vaccine i..

Appropriate pneumococcal vaccination in infants in Fiji

DESCRIPTION (provided by applicant): The Fiji Pneumococcal Project that has been funded by NIH has been designed to provide all the informat..

Grants

Awarded by National Institute of Allergy and Infectious Diseases

Citation metrics

47Scopus

32Web of Science

47Dimensions

Keywords

Pneumonia & Influenza

Biotechnology

Vaccine Related

3.4 Vaccines

Pediatric Research Initiative

Infectious Diseases

Infection

Prevention

Life Sciences & Biomedicine

Immunology

Lung

3 Good Health and Well Being

32 Biomedical and Clinical Sciences

Localization

Emerging Infectious Diseases

Conjugate Vaccine

Allergy

Pneumonia